Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 290,383 | 249,253 | 240,678 | 234,422 | 282,648 |
| Cost of Goods | 122,923 | 114,961 | 114,823 | 116,015 | 125,193 |
| Gross Profit | 167,460 | 134,292 | 125,855 | 118,407 | 157,455 |
| Operating Expenses | 160,089 | 158,116 | 178,488 | 239,300 | 158,230 |
| Operating Income | 8,294 | -22,863 | -51,810 | -120,878 | -582 |
| Interest Expense | 2,075 | 2,065 | 1,905 | 1,862 | 1,860 |
| Other Income | -1,537 | -215 | -4,007 | 651 | 2,458 |
| Pre-tax Income | 4,682 | -25,143 | -57,722 | -122,089 | 16 |
| Income Tax | 5,271 | -3,978 | -5,322 | 8,467 | -739 |
| Net Income Continuous | -589 | -21,165 | -52,400 | -130,556 | 755 |
| Net Income | $-589 | $-21,165 | $-52,400 | $-130,556 | $755 |
| EPS Basic Total Ops | 0.02 | -0.31 | -0.78 | -1.97 | N/A |
| EPS Basic Continuous Ops | 0.02 | -0.31 | -0.78 | -1.97 | 0.02 |
| EPS Diluted Total Ops | 0.02 | -0.31 | -0.78 | -1.97 | N/A |
| EPS Diluted Continuous Ops | 0.02 | -0.31 | -0.78 | -1.97 | 0.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.31 | -0.48 | -0.67 | -0.44 |
| EBITDA(a) | $11,490 | $-18,229 | $-47,610 | $-117,210 | $2,439 |